Stock Quote
Pharmaceuticals Biotechnology & Life Sciences (GICS 352)
The Pharmaceuticals, Biotechnology and Life Sciences sector includes biotechs, pharmaceutical companies and life science tool and service companies. It is made up of companies which are primarily engaged in the research, development, manufacturing and marketing of products based on genetic analysis and genetic engineering; companies working in the research, development and production of pharmaceuticals and drugs for humans and animals; and companies enabling the research, discovery and production of new drugs by supplying analytical tools, instruments, research services and supplies.
Top 20 Companies in this sector
| Ticker | Company | Last Traded | % Change |
|---|---|---|---|
| Celgene Corporation | 73.26 |
3.99% |
|
| IDEXX Laboratories Inc. | 54.25 |
3.95% |
|
| Merck & Co. Inc. | 32.22 |
1.42% |
|
| Genentech Inc. | 94.65 |
0.98% |
|
| Sanofi-Aventis | 36.29 |
0.78% |
|
| Johnson & Johnson | 68.66 |
0.57% |
|
| Gilead Sciences Inc. | 52.68 |
-0.04% |
|
| Amgen Inc. | 53.84 |
-0.15% |
|
| Hospira Inc. | 37.97 |
-0.21% |
|
| Human Genome Sciences Inc. | 6.96 |
-0.57% |
|
| Barr Pharmaceuticals Inc. | 65.91 |
-0.62% |
|
| Forest Laboratories Inc. | 35.05 |
-0.62% |
|
| Genzyme Corp. | 75.34 |
-0.76% |
|
| Novo Nordisk A/S | 60.64 |
-1.03% |
|
| Allergan Inc. | 52.44 |
-1.21% |
|
| Pfizer Inc. | 18.81 |
-1.36% |
|
| Glaxosmithkline plc | 47.42 |
-2.55% |
|
| Mylan, Inc. | 13.12 |
-2.74% |
|
| Teva Pharmaceutical Industries Ltd. | 45.10 |
-3.07% |
|
| Elan Corp. plc | 32.34 |
-3.58% |
Sponsored Links
Most Recent Posts in this sector:
InvestorPlaceBlogs.com - Bull/Bear Report -- Elan Pharmaceuticals - A miracle for patients and investors alike?
July 3, 2008 02:08 PM
Psychology of the market is everything and right now that psychology is decidedly negative. As such, stock values are depressed as participants toss the baby with the bathwater. Even the positive stories are seeing dampened enthusiasm. Take our stock of...
[ more ... ]
Strategy Lab Open - Elan Pharmaceuticals: Just what the stock doctor ordered?
June 27, 2008 06:26 PM
Despite a horrible environment for stocks, investors are still willing to reward companies that innovate with products that can deliver huge revenue growth. Such is the case with Elan Pharmaceuticals (ELN). The company recently announced positive trial for an Alzheimer...
[ more ... ]
InvestorPlaceBlogs.com - Baby Boomers Go 'Bionic' as Body Replacement Devices Soar in Popularity
April 23, 2008 09:27 AM
Many of us old enough to recall the 1970s TV show "The Six Million Dollar Man," know it was about a guy severely injured in a plane crash who was subsequently "rebuilt" in a high-tech, clandestine medical procedure costing six...
[ more ... ]
InvestorPlaceBlogs.com - Cepheid (CPHD): A False Hit Based on a False Claim
March 13, 2008 04:52 PM
Before you read this post, please know that I do not own this stock, although I do recommend it in my service. I'm exposing this because it's a hatchet job done on a product category that can save tens-of-thousands of...
[ more ... ]
Trending123 Blog - M&A In High Tech Bio Celgene Completes $2.9 Billion Acquisition of Pharmion
March 7, 2008 05:37 PM
Get information about the Celgene corporation, a multinational biopharmaceutical company committed to improving the lives of patients worldwide.
[ more ... ]
| Votes | Post Title |
|---|---|
| 3 | PFE- Big pharma |
Top 5 Income Stocks
The stocks that profited under the Bush tax cuts will no longer enjoy the growth and profits that they once did. If you continue to hold on to them when the tax cuts expire, my friend, you could lose 30%, 40%, even 50% of your wealth. That's why it's crucial that you reposition your assets now. Find out where the big money will be made.
Join the Community
InvestorPlace Blogs has created a community of bloggers dedicated to bringing investors like you in-depth, actionable and rated coverage and insights on individual stocks, sectors, and investing in general. Our proprietary ratings and rankings, powered by Marketocracy, allow you to rate—and gauge—how valuable a particular piece of research, post or stock pick are to you. InvestorPlaceblogs.com is a division of InvestorPlace Media, LLC, formerly known as Phillips Investment Resources.
InvestorPlace Blogs is powered by Marketocracy. Marketocracy has authorized Investor Place Blogs as an official registrar for voting through Marketocracy¹s Investment Research Rating service. Registered members of InvestorPlace Blogs are linked with a Marketocracy account to establish voting power based on their performance of trading and posting on stocks.
Strategy Lab Open
Strategy Lab Open (SLO) is a joint venture among InvestorPlace Blogs, Marketocracy and MSN’s Strategy Lab, and is the new MSN Strategy Lab Qualifying Tournament. We're looking for the next great undiscovered investing guru. Someone who doesn't just pick hot stocks but who invests well, makes money and can teach others to do the same.
Strategy Lab Open offers fans of MSN Strategy Lab a chance to play along with the pros. The winner of the Open, as determined by both overall portfolio performance as well as ratings of blog posts, will then go on to compete with well-known Wall Street pros in MSN’s popular Strategy Lab.
